Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Amyris and Givaudan Close Deal - Happi
Company News

Amyris and Givaudan Close Deal

Long-term manufacturing agreement for Neossance Squalane, Neossance Hemisqualane and CleanScreen.

Amyris, Inc. has completed the previously announced strategic transaction with Givaudan SA for the worldwide exclusive licensing of certain cosmetic ingredients, including Neossance Squalane, Neossance Hemisqualane and CleanScreen.

“We are very pleased with the expansion of our long-term partnership with Givaudan,” said John Melo, president and CEO. “This transaction marks the continuation of the successful execution of our strategy to develop, scale and make the world's best-performing molecules from clean, sustainable chemistry and to partner with the world's leading companies. We own the technology, and we formulate and deliver the best-performing consumer products through our portfolio of best-in-category consumer brands, which drives market demand and adoption of our ingredients. Our ingredients partners use their market reach to ensure a steady, reliable supply to leading beauty and personal care companies.”

The terms of the deal include a combination of a $200 million upfront cash consideration and up to a $150 million performance based earnout, along with a long-term manufacturing agreement that values the total transaction at an estimated $500 million.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters